These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
9. Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice. Barbieri S; Hofele K; Wiederhold KH; Probst A; Mistl C; Danner S; Kauffmann S; Sommer B; Spooren W; Tolnay M; Bilbe G; van der Putten H Adv Exp Med Biol; 2001; 487():147-67. PubMed ID: 11403156 [No Abstract] [Full Text] [Related]
10. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Chen L; Feany MB Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418 [TBL] [Abstract][Full Text] [Related]
11. Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Goedert M; Spillantini MG Mol Psychiatry; 1998 Nov; 3(6):462-5. PubMed ID: 9857966 [No Abstract] [Full Text] [Related]
12. How not to synthesize synuclein. Wilhelmsen KC Neurology; 2004 Sep; 63(5):770-1. PubMed ID: 15365120 [No Abstract] [Full Text] [Related]
13. Clinical and neuropathological features: session III summary and research needs. Forno L; Langston JW Neurotoxicology; 2001 Dec; 22(6):833-5. PubMed ID: 11829417 [No Abstract] [Full Text] [Related]
14. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Conway KA; Harper JD; Lansbury PT Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558 [TBL] [Abstract][Full Text] [Related]
15. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Bayersdorfer F; Voigt A; Schneuwly S; Botella JA Neurobiol Dis; 2010 Oct; 40(1):113-9. PubMed ID: 20211259 [TBL] [Abstract][Full Text] [Related]
16. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. Pendleton RG; Parvez F; Sayed M; Hillman R J Pharmacol Exp Ther; 2002 Jan; 300(1):91-6. PubMed ID: 11752102 [TBL] [Abstract][Full Text] [Related]
17. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. Haywood AF; Staveley BE BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075 [TBL] [Abstract][Full Text] [Related]